公开(公告)号：US20230301558A1

公开(公告)日：2023-09-28

申请号：US18176301

申请日：2023-02-28

Applicant: Dexcom, Inc.

Inventor： Mark Shults ,  Rathbun Rhodes ,  Stuart Updike ,  James H. Brauker

IPC: A61B5/145 ,  A61B5/1486 ,  A61B5/00 ,  A61B5/1495 ,  A61B5/15

CPC classification number: A61B5/14532 ,  A61B5/14865 ,  A61B5/0002 ,  A61B5/0031 ,  A61B5/145 ,  A61B5/14503 ,  A61B5/1495 ,  A61B5/150022 ,  A61B5/6846

Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous and subcutaneous measurement of glucose in a host.

公开(公告)号：US11770863B2

公开(公告)日：2023-09-26

申请号：US17456476

申请日：2021-11-24

Applicant: Dexcom, Inc.

Inventor： Aditya Mandapaka ,  Douglas William Burnette ,  Hari Hampapuram ,  Francis William Pascual ,  James Stephen Amidei ,  Darin Edward Chum Dew ,  Apurv Ullas Kamath ,  Nathanael Paul ,  William A. Pender ,  Michael A. Ploof

IPC: H04B17/318 ,  H04Q9/00 ,  H04W76/10 ,  A61B5/00 ,  H04B17/391 ,  A61B5/145

CPC classification number: H04W76/10 ,  A61B5/0004 ,  A61B5/0031 ,  H04B17/318 ,  H04B17/391 ,  H04Q9/00 ,  A61B5/14503 ,  A61B5/14532 ,  A61B5/14546 ,  H04Q2209/40 ,  H04Q2209/86 ,  H04Q2209/88

Abstract: Systems, devices, and methods are disclosed for wireless communication of analyte data. In this regard, in embodiments, a mobile includes a transceiver configured to transmit and receive wireless signals. The mobile device includes circuitry operatively coupled to the transceiver. The mobile device also includes a non-transitory computer-readable medium operatively coupled to the circuitry and storing instructions that, when executed, cause the mobile device to perform a number of operations. One such operation is to obtain a derivative of a first signal received via a first link. Another such operation is to obtain a derivative of a second signal received via a second link; and. Yet another such operation is to generate a selection for connection to an analyte sensor system, based on a comparison of the derivative of the first signal and the derivative of the second signal.

公开(公告)号：US20230293067A1

公开(公告)日：2023-09-21

申请号：US18201114

申请日：2023-05-23

Applicant: DexCom, Inc.

Inventor： Peter C. Simpson ,  Jennifer Blackwell ,  Sebastian Bohm ,  Michael J. Estes ,  Jeff Jackson ,  Jason Mitchell ,  Jack Pryor ,  Daiting Rong ,  Sean T. Saint ,  Disha B. Sheth ,  Shanger Wang

IPC: A61B5/1473 ,  A61B5/145

CPC classification number: A61B5/1473 ,  A61B5/14532

Abstract: Sensor devices including dissolvable tissue-piercing tips are provided. The sensor devices can be used in conjunction with dissolvable needles configured for inserting the sensor devices into a host. Hardening agents for strengthening membranes on sensor devices are also provided. Methods of using and fabricating sensor devices are also provided.

公开(公告)号：US20230293058A1

公开(公告)日：2023-09-21

申请号：US18167458

申请日：2023-02-10

Applicant: Dexcom, Inc.

Inventor： Daiting Rong ,  Sebastian Bohm ,  Matthew D. Wightlin

IPC: A61B5/145 ,  A61B5/1486

CPC classification number: A61B5/14532 ,  A61B5/14865 ,  A61B2560/0223 ,  A61B2562/043 ,  A61B2562/125 ,  A61B2562/0209

Abstract: Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes an electrochemical sensor incorporating a silver/silver chloride reference electrode, wherein a capacity of the reference electrode is controlled.

公开(公告)号：US20230284944A1

公开(公告)日：2023-09-14

申请号：US18198085

申请日：2023-05-16

Applicant: Dexcom, Inc.

Inventor： Shanger Wang ,  Devon M. Headen ,  Sebastian Bohm ,  Jonathan Hughes ,  Ted Tang Lee ,  Peter C. Simpson ,  Jiong Zou

IPC: A61B5/1486 ,  A61B5/00 ,  C12Q1/00 ,  A61B5/145 ,  C12Q1/54

CPC classification number: A61B5/14865 ,  A61B5/0022 ,  C12Q1/006 ,  C12Q1/002 ,  A61B5/14532 ,  A61B5/14546 ,  C12Q1/54 ,  G01N27/3271

Abstract: Flexible analyte sensors are provided. Flexible analyte sensors may be flexible continuous analyte sensors that facilitate continuous monitoring of an analyte such as blood glucose. The flexible analyte sensor may have a relatively flexible conductive or non-conductive core, may be formed from a plurality of substantially planar layers, or may be configured to transform from a freestanding sensor ex vivo to a non-freestanding sensor in vivo.

公开(公告)号：US11744943B2

公开(公告)日：2023-09-05

申请号：US16852369

申请日：2020-04-17

Applicant: DexCom, Inc.

Inventor： John Michael Dobbles ,  Apurv Ullas Kamath ,  Aarthi Mahalingam ,  James H. Brauker

IPC: A61M5/172 ,  A61B5/145 ,  A61M5/142 ,  A61M11/00 ,  A61M15/00 ,  G16H40/63 ,  G16H20/17 ,  A61M35/00 ,  A61M5/20 ,  A61B5/00 ,  A61M5/00 ,  A61M5/178 ,  A61M5/30

CPC classification number: A61M5/1723 ,  A61B5/14532 ,  A61B5/14546 ,  A61M5/14244 ,  A61M5/14276 ,  A61M5/20 ,  A61M11/00 ,  A61M15/008 ,  A61M15/0065 ,  A61M15/0068 ,  A61M15/0083 ,  A61M35/00 ,  G16H20/17 ,  G16H40/63 ,  A61B5/0031 ,  A61M5/003 ,  A61M5/178 ,  A61M5/30 ,  A61M15/00 ,  A61M2005/14296 ,  A61M2205/3569 ,  A61M2205/50 ,  A61M2205/502 ,  A61M2205/52 ,  A61M2205/581 ,  A61M2205/582 ,  A61M2205/587 ,  A61M2205/8206 ,  A61M2230/201

Abstract: Systems and methods for integrating a continuous glucose sensor 12, including a receiver 14, a medicament delivery device 16, a controller module, and optionally a single point glucose monitor 18 are provided. Integration may be manual, semi-automated and/or fully automated.

公开(公告)号：US20230248273A1

公开(公告)日：2023-08-10

申请号：US18190831

申请日：2023-03-27

Applicant: Dexcom, Inc.

Inventor： Phil MAYOU ,  Hari HAMPAPURAM ,  David A. PRICE ,  Keri J. LEONE ,  Kostyantyn SNISARENKO ,  Michael Robert MENSINGER ,  Leif N. BOWMAN ,  Robert J. BOOCK ,  Apurv Ullas KAMATH ,  Eli REIHMAN ,  Peter C. SIMPSON

IPC: A61B5/145 ,  G16H50/70 ,  G16H50/20 ,  G16H15/00

CPC classification number: A61B5/14532 ,  G16H50/70 ,  G16H50/20 ,  G16H15/00 ,  Y02A90/10

Abstract: Systems and methods for detecting and reporting patterns in analyte concentration data are provided. According to some implementations, an implantable device for continuous measurement of an analyte concentration is disclosed. The implantable device includes a sensor configured to generate a signal indicative of a concentration of an analyte in a host, a memory configured to store data corresponding at least one of the generated signal and user information, a processor configured to receive data from at least one of the memory and the sensor, wherein the processor is configured to generate pattern data based on the received information, and an output module configured to output the generated pattern data. The pattern data can be based on detecting frequency and severity of analyte data in clinically risky ranges.

公开(公告)号：US20230240589A1

公开(公告)日：2023-08-03

申请号：US18163829

申请日：2023-02-02

Applicant: Dexcom, Inc.

Inventor： Partha Pratim RAY ,  Matthew L. JOHNSON ,  Qi AN ,  Jason M. HALAC ,  Rush BARTLETT ,  John PADERI

IPC: A61B5/00 ,  A61B5/145 ,  A61B5/1486 ,  G16H10/60 ,  G16H40/67

CPC classification number: A61B5/4244 ,  A61B5/14546 ,  A61B5/14532 ,  A61B5/14865 ,  A61B5/7275 ,  A61B5/7246 ,  A61B5/7289 ,  A61B5/4866 ,  A61B5/7267 ,  A61B5/4848 ,  G16H10/60 ,  G16H40/67

Abstract: Certain aspects of the present disclosure relate to methods and systems for generating and utilizing analyte measurements. In certain aspects, a monitoring system comprises a continuous analyte sensor configured generate analyte measurements associated with analyte levels of a patient and a sensor electronics module coupled to the continuous analyte sensor and configured to receive and process the analyte measurements.

公开(公告)号：US11712182B2

公开(公告)日：2023-08-01

申请号：US17114204

申请日：2020-12-07

Applicant: DexCom, Inc.

Inventor： Andrew Scott Parker ,  Annika Emilie Kristina Jimenez ,  Chad Patterson ,  Subrai Girish Pai ,  Apurv Ullas Kamath

IPC: A61B5/145 ,  G06N3/08 ,  A61B5/00 ,  G16H40/67 ,  G16H50/50 ,  G16H10/60 ,  G16H50/30 ,  G16H50/70 ,  G16H50/20 ,  A61B5/16 ,  G06Q30/0201

CPC classification number: A61B5/14532 ,  A61B5/0004 ,  A61B5/0022 ,  A61B5/167 ,  A61B5/4833 ,  A61B5/4842 ,  A61B5/7264 ,  A61B5/7275 ,  A61B5/742 ,  A61B5/7475 ,  G06N3/08 ,  G06Q30/0201 ,  G16H10/60 ,  G16H40/67 ,  G16H50/20 ,  G16H50/30 ,  G16H50/50 ,  G16H50/70

Abstract: Multi-state engagement with continuous glucose monitoring (CGM) systems is described. Given the number of people that wear CGM systems and because CGM systems produce measurements continuously, a platform that provides a CGM system may have an enormous amount of data. This amount of data is practically, if not actually, impossible for humans to process. In implementations, a CGM platform includes a data analytics platform that obtains packages of glucose measurements provided by a CGM system and also obtains additional data associated with a user. The data analytics platform generates state information for the user by processing these CGM packages and the additional data, at least in part, by using one or more models. Based on this state information, the data analytics platform controls communication with the user, which may include generating intervention strategies to prevent users from transitioning to a negative state such as discontinuing use of the CGM system.

公开(公告)号：US11696706B2

公开(公告)日：2023-07-11

申请号：US17114211

申请日：2020-12-07

Applicant: DexCom, Inc.

Inventor： Andrew Scott Parker ,  Annika Emilie Kristina Jimenez ,  Chad Patterson ,  Subrai Girish Pai ,  Apurv Ullas Kamath

IPC: A61B5/145 ,  G06N3/08 ,  A61B5/00 ,  G16H40/67 ,  G16H50/50 ,  G16H10/60 ,  G16H50/30 ,  G16H50/70 ,  G16H50/20 ,  A61B5/16 ,  G06Q30/0201

CPC classification number: A61B5/14532 ,  A61B5/0004 ,  A61B5/0022 ,  A61B5/167 ,  A61B5/4833 ,  A61B5/4842 ,  A61B5/7264 ,  A61B5/7275 ,  A61B5/742 ,  A61B5/7475 ,  G06N3/08 ,  G06Q30/0201 ,  G16H10/60 ,  G16H40/67 ,  G16H50/20 ,  G16H50/30 ,  G16H50/50 ,  G16H50/70

Abstract: Multi-state engagement with continuous glucose monitoring (CGM) systems is described. Given the number of people that wear CGM systems and because CGM systems produce measurements continuously, a platform that provides a CGM system may have an enormous amount of data. This amount of data is practically, if not actually, impossible for humans to process. In implementations, a CGM platform includes a data analytics platform that obtains packages of glucose measurements provided by a CGM system and also obtains additional data associated with a user. The data analytics platform generates state information for the user by processing these CGM packages and the additional data, at least in part, by using one or more models. Based on this state information, the data analytics platform controls communication with the user, which may include generating intervention strategies to prevent users from transitioning to a negative state such as discontinuing use of the CGM system.